Parkinson's disease (PD) is the second most common form of neurodegenerative disease and afflicts more than 10 million people ...

Stacked appointments, new medications and meeting with the requirements of insurance policies are routine for those living with Parkinson’s disease. In rural states like Wyoming, patients ...

New research presented today (Wednesday) at the Federation of European Neuroscience Societies (FENS) Forum 2026 has ...

Researchers at the Icahn School of Medicine at Mount Sinai have found that patients with Parkinson's disease undergoing deep ...

A study published in Cannabis and Cannabinoid Research examined the effects of medical cannabis on patients diagnosed with ...

Parkinson's disease prevention may be more possible than previously thought. Research links pesticides, TCE, and air ...

Kenai Therapeutics, a clinical-stage biotechnology company pioneering next generation approaches to cure neurological conditions, today announced the completion of enrollment for the REPLACE™ Phase 1b ...

Following recent speculation about his health and show cancellations, Foxton has publicly talked about his life-changing ...

A drug that showed promise in treating a sleep disorder could potentially help slow symptoms, experts say.

In a world first Australian researchers will test a one-off therapy that could replace damaged brain cells in people with ...

CDC reports show Ohio's Parkinson's death rate among adults 65 and older was lower than Utah's 102.1 per 100,000 but remains ...

In a recent review published in the journal Molecular Psychiatry, researchers collated decades of literature on the co-occurrence of depression with neurodegenerative diseases, particularly ...